arrow_back Back to App

Protecting Pharmacies in Medicaid: Transparent Drug Payments

This act aims to ensure pharmacies receive fair payments for drugs under Medicaid and to prevent unfair pricing practices. This means drug prices will be more transparent, potentially impacting the stability of drug access and pharmacy services for Medicaid beneficiaries.
Key points
Introduces monthly surveys of pharmacy drug prices to determine national average acquisition costs, ensuring fair payments.
Pharmacies must respond to price surveys; refusal or false information can result in civil penalties up to $100,000.
Prohibits abusive "spread pricing" where intermediaries take excessive margins, ensuring funds reach pharmacies.
Increases oversight of drug payments in Medicaid, including how pharmacy benefit managers handle reimbursements to pharmacies.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_S_927
Sponsor: Sen. Welch, Peter [D-VT]
Process start date: 2025-03-11
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Protecting Pharmacies in Medicaid Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_S_927.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2025-03-11.

What are the main provisions?

Key points include:

  • Introduces monthly surveys of pharmacy drug prices to determine national average acquisition costs, ensuring fair payments.
  • Pharmacies must respond to price surveys; refusal or false information can result in civil penalties up to $100,000.
  • Prohibits abusive "spread pricing" where intermediaries take excessive margins, ensuring funds reach pharmacies.
  • Increases oversight of drug payments in Medicaid, including how pharmacy benefit managers handle reimbursements to pharmacies.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Welch, Peter [D-VT].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health